BRAIN Biotech AG (LON:0RFI)
London
· Delayed Price · Currency is GBP · Price in EUR 2.830
+0.020 (0.71%)
At close: Feb 21, 2025
BRAIN Biotech AG Revenue
In the fiscal year ending September 30, 2024, BRAIN Biotech AG had annual revenue of 55.50M EUR, down -1.29%. BRAIN Biotech AG had revenue of 14.43M in the quarter ending September 30, 2024, a decrease of -5.02%.
Revenue
55.50M EUR
Revenue Growth
-1.29%
P/S Ratio
n/a
Revenue / Employee
174.53K EUR
Employees
318
Market Cap
51.84M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 55.50M | -726.00K | -1.29% |
| Sep 30, 2023 | 56.23M | 5.93M | 11.79% |
| Sep 30, 2022 | 50.30M | 11.07M | 28.23% |
| Sep 30, 2021 | 39.22M | 158.00K | 0.40% |
| Sep 30, 2020 | 39.06M | -982.00K | -2.45% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| BP p.l.c. | 149.68B |
| British American Tobacco p.l.c. | 25.87B |